Anar al contingut
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Tots els camps
Títol
Autor
Matèria
Signatura
ISBN/ISSN
Etiqueta
Trobar
Avançada
Detection of broad functional...
Citar
Enviar aquest missatge de text
Enviar per correu electrònic aquest
Imprimir
Exportar registre
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enllaç permanent
Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
Dades bibliogràfiques
Autors principals:
Ondondo, B
,
Yang, H
,
Dong, T
,
de Gleria, K
,
Suttill, A
,
Conlon, C
,
Brown, D
,
Williams, P
,
Bowness, P
,
Rowland-Jones, S
,
Hanke, T
,
McMichael, A
,
Dorrell, L
Format:
Journal article
Publicat:
2006
Fons
Descripció
Ítems similars
Visualització del personal
Ítems similars
Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
per: Rowland-Jones Sarah L, et al.
Publicat: (2006-12-01)
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
per: Ondondo, B, et al.
Publicat: (2006)
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
per: Dorrell, L, et al.
Publicat: (2007)
Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
per: Dorrell, L, et al.
Publicat: (2006)
pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
per: Ondondo, B, et al.
Publicat: (2005)